Bulgaria
2006: Reimbursement of anti-dementia drugs
Related News
The availability of medicines in general
Alzheimer Europe was unable to obtain detailed information on the general reimbursement system of medicines in Bulgaria.
The availability of Alzheimer treatments
According to Alzheimer Bulgaria, except for memantine, all anti-dementia treatments are available in Bulgaria, but none of them are part of the reimbursement system in that country and patients and carers need to cover these costs themselves.
Rivastigmine | Galantamine | Memantine |
||
Reimbursement | No | No | No | No |
Initial treatment decision | N/A | N/A | N/A | N/A |
Continuing treatment decision | N/A | N/A | N/A | N/A |
Required examinations | N/A | N/A | N/A | N/A |
MMSE limits | N/A | N/A | N/A | N/A |
People living alone | N/A | N/A | N/A | N/A |
People in nursing homes | N/A | N/A | N/A | N/A |
Last Updated: Monday 07 June 2010